Soleno Therapeutics, Inc. · NASDAQ:SLNO

T. Rowe Price Associates Inc reported a 5.20% stake in Soleno Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2025 · Filed May 14, 2025

T. Rowe Price Associates Inc reported a 5.20% stake in Soleno Therapeutics, Inc., 2,400,788 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G).

Stake
5.20%
Shares
2,400,788
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
T. Rowe Price Associates, Inc.5.20%2,400,788

Source

View original at SEC

Related